Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Department of Orthopedics, The Third People's Hospital of Hubei Province, Wuhan, Hubei, China.
Braz J Med Biol Res. 2021 Apr 19;54(6):e10474. doi: 10.1590/1414-431X202010474. eCollection 2021.
Osteosarcoma is a highly malignant tumor that occurs in the bone. Previous studies have shown that multiple microRNAs (miRNAs) regulate the development of osteosarcoma. This study aimed to explore the role of miR-629-5p and its target gene, caveolin 1 (CAV1), in osteosarcoma development. To analyze the expression of miR-629-5p and CAV1 mRNA in osteosarcoma tissues and cell lines, qRT-PCR analysis was performed. Dual-luciferase reporter experiments were subsequently performed to validate the relationship between CAV1 and miR-629-5p. CCK8 assay was used to measure osteosarcoma cell proliferation, and wound-healing assay was performed to study their migratory phenotype. Our findings revealed that miR-629-5p was overexpressed in osteosarcoma tissues and cells, and thereby enhanced cell proliferation and migration. Further, we validated that miR-629-5p targets CAV1 mRNA directly. CAV1 expression, which was negatively correlated with miR-629-5p expression, was found to be downregulated in osteosarcoma tissue samples. Moreover, our data showed that an increase in CAV1 level led to a decline in osteosarcoma cell proliferation and migration, which could be rescued by miR-629-5p upregulation. Overall, our study confirmed that miR-629-5p promoted osteosarcoma proliferation and migration by directly inhibiting CAV1.
骨肉瘤是一种发生在骨骼中的高度恶性肿瘤。先前的研究表明,多种 microRNAs(miRNAs)调节骨肉瘤的发展。本研究旨在探讨 miR-629-5p 及其靶基因小窝蛋白 1(CAV1)在骨肉瘤发展中的作用。为了分析 miR-629-5p 和 CAV1mRNA 在骨肉瘤组织和细胞系中的表达,进行了 qRT-PCR 分析。随后进行了双荧光素酶报告实验以验证 CAV1 与 miR-629-5p 之间的关系。CCK8 测定法用于测量骨肉瘤细胞增殖,划痕愈合测定法用于研究其迁移表型。我们的研究结果表明,miR-629-5p 在骨肉瘤组织和细胞中过度表达,从而增强了细胞的增殖和迁移。此外,我们验证了 miR-629-5p 直接靶向 CAV1mRNA。在骨肉瘤组织样本中发现 CAV1 表达下调,其表达与 miR-629-5p 表达呈负相关。此外,我们的数据表明,CAV1 水平的增加导致骨肉瘤细胞增殖和迁移减少,而 miR-629-5p 的上调可使其恢复。总的来说,我们的研究证实 miR-629-5p 通过直接抑制 CAV1 促进骨肉瘤的增殖和迁移。